RecruitingNot ApplicableNCT06894277

An Interactive Education Program to Reduce High Risk Behavior in Adolescents Ph II (iTRAC HERO)

An Interactive Education Program to Reduce High Risk Behavior in Adolescents Ph II


Sponsor

Klein Buendel, Inc.

Enrollment

120 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Using the efficacious iTRAC intervention to enhance emotion regulation competencies as a foundation, this study will create and test iTRAC-HERO to teach emotion regulation skills in the context of sexual health education.


Eligibility

Min Age: 12 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called iTRAC-HERO for people with adolescent behavior, emotion regulation, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 14 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALiTRAC-HERO

iTRAC-HERO will consist of eight, approximately 45-minute, "gamified" digital modules of 4-6 activities (games, videos, etc.). No instruction is needed to use the program. Content will use gender- and sexuality-inclusive language and avoid heteronormative descriptions of risk. This content will include strategies for (and practice with) recognizing and managing emotions, particularly in relation to sexual health situations, to enhance the likelihood that the emotion regulation and sexual health education provided can be applied to experiences that are emotionally arousing and lead to risk.


Locations(1)

Klein Buendel, Inc.

Golden, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06894277


Related Trials